pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
  1. pharmadog
  2. ›drugs
  3. ›Tracleer
drug
save

Tracleer

Marketedupdated 3mo ago
by Janssen-Cilag Holdings Inc (Inactive)
Approved
community read0 votes

🐶 often sniffed alongside

top 5
  • tagApproval310 co-mentions · 108 sources
  • drugbosentan ODT249 co-mentions · 108 sources
  • drugBOSENTAN249 co-mentions · 108 sources
  • tagSmall Molecule155 co-mentions · 108 sources
  • companyNATCO Pharma Inc.10 co-mentions · 10 sources

all catalysts(0)

nothing on the calendar yet

Trials studying Tracleer

  • phase2Effect of Bosentan in Patients With Metastatic Melanoma Treated With Dacarbazine (DTIC)completedn=80
  • phase1A Study in Healthy Men to Test Whether Bosentan Influences the Amount of BI 425809 in the Bloodcompletedn=14
  • phase2Preventive Effects of Bosentan on the Systemic Cardiovascular Consequence of Sleep Apneacompletedn=19
  • phase1A Study in Healthy Men to Test How Bosentan Influences the Amount of Nerandomilast in the Bloodcompletedn=16
  • phase1Study to Evaluate the Effect of Bosentan on the Pharmacokinetics of Lurbinectedin in Patients With Advanced Solid Tumorscompletedn=11
  • phase3FUTURE 3 Study Extensioncompletedn=58
  • phase3Open Label Extension Study in Patients With Idiopathic Pulmonary Fibrosis Who Completed Protocol AC-052-321/ BUILD 3 / NCT00391443completedn=128
  • phase3Efficacy and Safety of Bosentan in Sickle Cell Disease (SCD) Patients With Pulmonary Arterial Hypertension (PAH)terminatedn=14
more trials →

News(0)

no news has mentioned this drug yet

brand
Tracleer
generic
bosentan
indication
Pulmonary Arterial Hypertension
phase
marketed
Data sources
ClinicalTrials.gov
last refreshed 8m ago
Found something off?
🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?